Skip to main content

Change location

You are currently on the Canada (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (Español)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Canada (English)
  • Careers
  • Media and News
  • Get in touch
    • Canada (English)
    • We are Bracco
    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
    • Product overview
      • X-ray/CT
      • Contrast agents

        • Gastrografin
        • ISOVUE
      • Medical devices

        • Protoco2l Touch
        • CT Exprès 3D
        • EmpowerCTA+
      • Fluoroscopy
        • E-Z-HD
        • E-Z-PAQUE
        • Liquid POLIBAR PLUS
        • Varibar
      • MRI
      • Contrast agents

        • VUEWAY
        • MultiHance
        • ProHance
      • Medical Devices

        • EmpowerMR
      • CEUS
      • Contrast agents

        • SonoVue
      • Molecular imaging
      • Contrast agents

        • Choletec
        • Kinevac
      • Cardiovascular
      • Contrast agents

        • ISOVUE
      • Medical devices

        • ACIST CVi
        • ACIST RXi
    • Digital health
    • Oncology
    • Cardiology
    • Innovation
    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
    • Education
    • Next-Gen Projects
    • Our Partnerships
  • Events
  • Sustainability
  • Our Stories
101 results found
Product
VUEWAY® (gadopiclenol) ISI VUEWAY® injection is the new Bracco contrast agent, with the highest relaxivity of all GBCAs today combined with high stability, making effective MRI contrast enhancement possible at half the gadolinium dose.
No image available

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2026 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182